MSLN and familial pancreatic carcinoma: Based on this mechanism, the anti-MSLN-7 × 19 CAR-T cells constructed showed superior migration ability to traditional anti-MSLN CAR-T cells in vitro studies and demonstrated stronger infiltration and killing effects on MSLN-positive pancreatic cancer cell lines (AsPC-1) in xenograft models.